Haemophilia

Commentary: `Switching between full-length and B-domain deleted Factor VIII and the risk of inhibitors'
pp. 561-562(2)
Author: HOOTS, W. K.

The 80th anniversary of von Willebrand's disease: history, management and research
pp. 563-572(10)
Authors: FEDERICI, A. B.; BERNTORP, E.; LEE, C. A.

The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors
pp. 573-578(6)
Author: GOMPERTS, E. D.

Epidemiology of inhibitor formation with recombinant factor VIII replacement therapy
pp. 579-590(12)
Authors: PEERLINCK, K.; HERMANS, C.

Application of current knowledge to the management of bleeding events during immune tolerance induction
pp. 591-597(7)
Authors: DI PAOLA, J.; ALEDORT, L.; BRITTON, H.; CARCAO, M.; GRABOWSKI, E.; HUTTER, J.; JOURNEYCAKE, J.; KEMPTON, C.; LEISSINGER, C.

Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography
pp. 598-604(7)
Authors: YOUNG, G.; BLAIN, R.; NAKAGAWA, P.; NUGENT, D. J.

Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A
pp. 605-614(10)
Authors: GOLDENBERG, N. A.; HATHAWAY, W. E.; JACOBSON, L.; MCFARLAND, K.; MANCO-JOHNSON, M. J.

Identification of three FGA mutations in two Chinese families with congenital afibrinogenaemia
pp. 615-620(6)
Authors: FANG, Y.; DAI, B.-T.; WANG, X.-F.; FU, Q.-H.; DAI, J.; XIE, F.; CAI, X.-H.; WANG, H.-L.; WANG, Z.-Y.

Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain
pp. 621-624(4)
Authors: TODD, T.; PERRY, D. J.; HAYMAN, E.; LAWRENCE, K.; GATTENS, M.; BAGLIN, T.

Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin
pp. 625-628(4)
Authors: KADIR, R. A.; KINGMAN, C. E. C.; CHI, C.; O'CONNELL, N. M.; RIDDELL, A.; LEE, C. A.; ECONOMIDES, D. L.

Surface electrical stimulation of the quadriceps femoris in patients affected by haemophilia A
pp. 629-632(4)
Authors: QUEROL, F.; GALLACH, J. E.; TOCA-HERRERA, J. L.; GOMIS, M.; GONZALEZ, L-M.

Health-related quality of life in chronic coagulation disorders
pp. 633-642(10)
Authors: TALAULIKAR, D.; SHADBOLT, B.; MCDONALD, A.; PIDCOCK, M.

Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoL
pp. 643-653(11)
Authors: BRADLEY, C. S.; BULLINGER, M.; MCCUSKER, P. J.; WAKEFIELD, C. D.; BLANCHETTE, V. S.; YOUNG, N. L.

Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood-induced synovitis
pp. 654-662(9)
Authors: VALENTINO, L. A.; HAKOBYAN, N.

Rituximab treatment of mild haemophilia A with inhibitors: a proposed treatment protocol
pp. 663-667(5)
Authors: DUNKLEY, S.; KERSHAW, G.; YOUNG, G.; WARBURTON, P.; LINDEMAN, R.; MATTHEWS, S.; RENNISSON, F.

Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period
pp. 668-671(4)
Authors: MAINWARING, C. J.; EVANS, J.; CHANA, J.; LEWIS, H.

Heterotropic bone formation as a complication of elective joint replacement in haemophilic patients - a case report and literature review
pp. 672-675(4)
Authors: MANN, H. A.; CHOUDHURY, M. Z. B.; LEE, C. A.; GODDARD, N. J.

Management of acute bleeding in a patient with congenital afibrinogenaemia
pp. 676-678(3)
Authors: VAKALOPOULOU, S.; RIZOPOULOU, D.; ZAFIRIADOU, E.; PERIFANIS, V.; TZIOMALOS, K.; LEFKOU, E.; HILL, M.; DOLAN, G.; GARIPIDOU, V.

The feasibility of total ankle prosthesis for severe arthropathy in haemophilia and prothrombin deficiency
pp. 679-682(4)
Authors: VAN DER HEIDE, H. J. L.; NOVÁKOVÁ, I.; DE WAAL MALEFIJT, M. C.

Torticollis as a sign of cervico-thoracic epidural haematoma in an infant with severe haemophilia A
pp. 683-686(4)
Authors: CUVELIER, G. D. E.; DAVIS, J. H.; PURVES, E. C.; WU, J. K.

Acquired von Willebrand's syndrome resulting from untreated hypothyroidism in two prepubertal girls
pp. 687-689(3)
Authors: GALLI-TSINOPOULOU, A.; STYLIANOU, C.; PAPAIOANNOU, G.; NOUSIA-ARVANITAKIS, S.

Switching between full-length and B-domain-deleted factor VIII and the risk of inhibitors
pp. 690-691(2)
Author: KEELING, D.

Keyword index
pp. 692-693(2)

Author index
pp. 694-696(3)